[Form 4] The Joint Corp. Insider Trading Activity

Rhea-AI Filing Summary

Christopher M. Grandpre, a director of The Joint Corp. (JYNT), reported two open-market purchases of the issuer's common stock in mid-August 2025. The filing shows a purchase of 14,388 shares on 08/15/2025 at a weighted average price of $10.8793 and a subsequent purchase of 10,000 shares on 08/18/2025 at a weighted average price of $10.6978. Following these transactions he beneficially owned 29,383 shares as a direct owner. The filing was submitted under a Form 4 and signed by an attorney-in-fact on 08/19/2025. No derivative transactions, dispositions, or additional contextual details about the purpose of the purchases are provided in this document.

Positive

• Director open-market purchases were reported, showing increased insider ownership to 29,383 shares.
• Transactions disclosed with weighted-average prices and explanatory footnotes, improving transparency about trade pricing.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchased 24,388 shares over three days, bringing direct holdings to 29,383 shares; transaction sizes are modest versus unknown company float.

The filing discloses routine open-market purchases by a director at weighted average prices of $10.8793 and $10.6978 on 08/15/2025 and 08/18/2025 respectively. These are non-derivative acquisitions reported on Form 4 and increase direct beneficial ownership to 29,383 shares. Without information on total shares outstanding or the director's prior holdings beyond the post-transaction total, the transactions are insufficient to assess materiality or valuation impact. For investors, director buying is a data point but not, by itself, a material corporate development in this filing.

Corporate Governance Expert

TL;DR: Insider open-market purchases were properly disclosed on Form 4 and signed by an authorized attorney-in-fact.

The report identifies the reporting person as a director and indicates the Form 4 was filed by one reporting person and executed by an attorney-in-fact on 08/19/2025. The filing includes explanatory footnotes clarifying that the reported prices are weighted averages from multiple trades. There is no indication of transactions pursuant to a 10b5-1 plan or any sale or derivative activity. Governance compliance appears met based on the disclosure provided, though the document contains no further context on intent or timing beyond the transaction dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grandpre Christopher M

(Last) (First) (Middle)

16767 NORTH PERIMETER DRIVE

SUITE 110

(Street)

SCOTTSDALE AZ 85260

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOINT Corp [ JYNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		P		14,388	A	$10.8793(1)	19,383	D
Common Stock	08/18/2025		P		10,000	A	$10.6978(2)	29,383	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.82 to $10.98, inclusive. The reporting person undertakes to provide to The Joint Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.69 to $10.70, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

	/s/ Andra Terrell , as attorney-in-fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Christopher M. Grandpre report for JYNT?

He reported two open-market purchases: 14,388 shares on 08/15/2025 at a weighted average $10.8793 and 10,000 shares on 08/18/2025 at a weighted average $10.6978.

How many JYNT shares does the reporting person beneficially own after these Form 4 transactions?

Following the reported transactions the reporting person beneficially owned 29,383 shares as a direct owner.

Were any derivative securities or dispositions reported in this Form 4 for JYNT?

No. The filing shows only non-derivative acquisitions (purchases) and no dispositions or derivative transactions are reported.

Does the filing indicate the purchases were made under a Rule 10b5-1 plan?

No. The form does not indicate these transactions were made pursuant to a 10b5-1 plan; no such plan reference is provided in the document.

Who signed the Form 4 filing for these transactions?

The Form 4 was signed by Andra Terrell, as attorney-in-fact on 08/19/2025.